Ex­clu­sive: NTx rais­es $47.5M Se­ries B to com­mer­cial­ize pro­tein, mR­NA man­u­fac­tur­ing plat­forms 

Ear­ly-stage bio­man­u­fac­tur­er Na­ture’s Tool­box (NTx) has col­lect­ed $47.5 mil­lion in a Se­ries B raise to bring its mR­NA and pro­tein pro­duc­tion plat­forms to mar­ket, as well as to dou­ble its head­count and ex­pand its Rio Ran­cho, NM fa­cil­i­ty.

NTx has two dif­fer­ent man­u­fac­tur­ing plat­forms: one called NTxscribe, which pro­duces mR­NA, and the oth­er is named NTx­press, which is de­signed to make pro­teins.

The Se­ries B is in­tend­ed to bring NTxscribe to mar­ket in the third quar­ter of 2024, with a pro­to­type avail­able in the first half of next year, CEO Jamie Cof­fin told End­points News in an in­ter­view. Mean­while, the pro­tein plat­form is in ear­li­er stages of de­vel­op­ment, he not­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER